Holen Sie sich die Stockscreener-App
7.48
3.04%
0.23
Schlusskurs vom Vortag:
$7.25
Offen:
$7.25
24-Stunden-Volumen:
2.82M
Relative Volume:
0.39
Marktkapitalisierung:
$1.31B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.2964
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
+5.06%
1M Leistung:
+8.26%
6M Leistung:
-18.89%
1J Leistung:
-42.09%
1-Tages-Spanne:
$7.24
$7.495
1-Wochen-Bereich:
$6.98
$7.72
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.475 | 1.24B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
242.68 | 39.03B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
65.23 | 11.29B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
98.36 | 7.90B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.24 | 11.14B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.44 | 7.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure - Benzinga
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? - TradingView
Current and Future Analysis of Virtual Care Platforms Market - openPR.com
Robust Growth in Digital Health Services Market (2025-2032): - openPR.com
Future Scope of Virtual Healthcare Services Market to Observe - openPR.com
Online Doctor Consultation Market: Trends, Growth, & Future - openPR.com
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - AOL.com
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - The Motley Fool
Robust Growth in Telemedicine Service Platform Market - openPR.com
TDOC Q1 Earnings Call: UpLift Acquisition and Integrated Care Growth Shape Teladoc’s Outlook - Yahoo Finance
Teladoc Health (NYSE:TDOC) Reports Q1 2025 Net Loss Of US$93 Million - Yahoo Finance
Telemedicine Market is Projected to grow at a CAGR of 16.8% - openPR.com
(TDOC) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit - MSN
Digital health companies faced a rocky start to 2025 - Modern Healthcare
Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now - Insider Monkey
Teladoc Health (TDOC) Price Target Lowered by Wells Fargo | TDOC Stock News - GuruFocus
Digital Health Market Generated Opportunities, Future Scope - openPR.com
ATA Nexus: Telehealth companies unite to change nutrition policy, bolstered by MAHA momentum - Fierce Healthcare
Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare - Quantisnow
Digital Healthcare Market Booms with AI Integration and Telehealth Services | Teladoc Health, Amwell, Philips - openPR.com
Teladoc Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your RightsTDOC - ACCESS Newswire
Teladoc Health, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsTDOC - ACCESS Newswire
Teladoc health advances virtual mental health with uplift acquisition and integrated solutions - MSN
Teladoc Health: No Real Rescue Insight (NYSE:TDOC) - Seeking Alpha
Teladoc Health Announces Employee Inducement Awards under NYSE R - GuruFocus
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - The Manila Times
Teladoc Strengthens Virtual Care Platform: Awards 267,000 Shares to Uplift Health Acquisition Team and Key Hire - Stock Titan
Teladoc bets $30m that insurance coverage can save BetterHelp - Healthcare Brew
Teladoc Health Acquires Virtual Mental Health Firm UpLift for Over - Hoodline
Surge in Call Options for Teladoc (TDOC) Indicates Bullish Sentiment | TDOC Stock News - GuruFocus
Teladoc call volume above normal and directionally bullish - TipRanks
Teladoc buys virtual mental health startup for $30M to aid struggling therapy business - Crain's New York Business
Teladoc Health, Inc. (NYSE:TDOC) Q1 2025 Earnings Call Transcript - MSN
Teladoc Inc. Earnings Call: Balancing Growth and Challenges - TipRanks
Citi cuts Teladoc price target to $8 from $8.75, keeps Buy rating - Investing.com Nigeria
Teladoc Health (TDOC) Price Target Lowered by Canaccord Genuity - GuruFocus
Teladoc Health, Inc. SEC 10-Q Report - TradingView
Teladoc Health (TDOC) Receives Price Target Adjustment from Gold - GuruFocus
Teladoc Health (TDOC) Receives Price Target Adjustment from Goldman Sachs | TDOC Stock News - GuruFocus
Teladoc Buys UpLift With Eye on Benefits Coverage Model for Mental Health - Healthcare Innovation
Teladoc Health (TDOC): Analyst Lowers Price Target, Maintains Ho - GuruFocus
Teladoc Health (TDOC) Price Target Lowered by Evercore ISI Group - GuruFocus
Teladoc Health (TDOC) Receives Reiterated Rating from Needham | - GuruFocus
Teladoc Health (TDOC) Price Target Lowered by Evercore ISI Group | TDOC Stock News - GuruFocus
Teladoc acquires mental health firm UpLift as BetterHelp earnings slide - Healthcare Dive
Canaccord cuts Teladoc stock target to $12, keeps buy rating - Investing.com
Canaccord cuts Teladoc stock target to $12, keeps buy rating By Investing.com - Investing.com India
Canaccord Adjusts Price Target for Teladoc (TDOC) Following Acqu - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):